We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Supreme Court to Hear Copaxone Patent Appeal
Teva scored a legal victory Monday when the U.S. Supreme Court agreed to hear its appeal of a lower court ruling invalidating a patent for the drugmaker’s blockbuster multiple sclerosis drug Copaxone.